PT731709E - Inibidores de neutrofilos provenientes nematodos - Google Patents

Inibidores de neutrofilos provenientes nematodos

Info

Publication number
PT731709E
PT731709E PT93911273T PT93911273T PT731709E PT 731709 E PT731709 E PT 731709E PT 93911273 T PT93911273 T PT 93911273T PT 93911273 T PT93911273 T PT 93911273T PT 731709 E PT731709 E PT 731709E
Authority
PT
Portugal
Prior art keywords
nematodes
neutrophils
inhibitors
providing
compositions
Prior art date
Application number
PT93911273T
Other languages
English (en)
Inventor
Georg Phillip Vlasuk
Matthew Moyle
David Lee Foster
Original Assignee
Corvas Int Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Corvas Int Inc filed Critical Corvas Int Inc
Publication of PT731709E publication Critical patent/PT731709E/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
    • C07K14/43536—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from worms
    • C07K14/4354—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from worms from nematodes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/53—Colony-stimulating factor [CSF]
    • C07K14/535—Granulocyte CSF; Granulocyte-macrophage CSF
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
    • F02—COMBUSTION ENGINES; HOT-GAS OR COMBUSTION-PRODUCT ENGINE PLANTS
    • F02B—INTERNAL-COMBUSTION PISTON ENGINES; COMBUSTION ENGINES IN GENERAL
    • F02B75/00—Other engines
    • F02B75/02—Engines characterised by their cycles, e.g. six-stroke
    • F02B2075/022—Engines characterised by their cycles, e.g. six-stroke having less than six strokes per cycle
    • F02B2075/027—Engines characterised by their cycles, e.g. six-stroke having less than six strokes per cycle four

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Immunology (AREA)
  • Rheumatology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pain & Pain Management (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PT93911273T 1992-05-11 1993-05-11 Inibidores de neutrofilos provenientes nematodos PT731709E (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US88172192A 1992-05-11 1992-05-11
US99697292A 1992-12-24 1992-12-24

Publications (1)

Publication Number Publication Date
PT731709E true PT731709E (pt) 2002-04-29

Family

ID=27128632

Family Applications (1)

Application Number Title Priority Date Filing Date
PT93911273T PT731709E (pt) 1992-05-11 1993-05-11 Inibidores de neutrofilos provenientes nematodos

Country Status (13)

Country Link
US (1) US6756211B1 (pt)
EP (1) EP0731709B1 (pt)
JP (1) JP3509860B2 (pt)
AT (1) ATE207498T1 (pt)
AU (1) AU687737B2 (pt)
CA (1) CA2135390A1 (pt)
DE (1) DE69331018T2 (pt)
DK (1) DK0731709T3 (pt)
ES (1) ES2168095T3 (pt)
MX (1) MX9302750A (pt)
NZ (3) NZ252591A (pt)
PT (1) PT731709E (pt)
WO (1) WO1993023063A1 (pt)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4733830B2 (ja) 1997-12-31 2011-07-27 ユニヴァーシティー オブ アイオワ リサーチ ファンデーション 自己免疫疾患の予防および抑制のための寄生生物剤の使用
EP1186303A3 (en) * 2000-09-06 2003-12-10 Pfizer Products Inc. Pharmaceutical combinations, for the treatment of stroke and traumatic brain injury, containing a neutrophil inhibiting factor and an selective NMDA-NR2B receptor antagonist
US8022040B2 (en) * 2004-11-29 2011-09-20 The Regents Of The University Of California Hydroxyapatite-binding peptides for bone growth and inhibition
DE102007021199B4 (de) * 2006-07-17 2016-02-11 Evonik Degussa Gmbh Zusammensetzungen aus organischem Polymer als Matrix und anorganischen Partikeln als Füllstoff, Verfahren zu deren Herstellung sowie deren Verwendung und damit hergestellte Formkörper
CN104411325B (zh) 2012-03-13 2017-06-06 詹姆斯库克大学 用于治疗炎症的方法
CA2924220A1 (en) 2013-09-18 2015-03-26 James Cook University Modified anti-inflammatory proteins and method of use
EP3554257B1 (en) 2016-12-15 2023-07-12 Société des Produits Nestlé S.A. Compositions and methods that modulate white blood cells or neutrophils in a companion animal

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4431739A (en) * 1979-11-05 1984-02-14 Genentech, Inc. Transformant bacterial culture capable of expressing heterologous protein
US4438032A (en) * 1981-01-30 1984-03-20 The Regents Of The University Of California Unique T-lymphocyte line and products derived therefrom
US5019648A (en) 1987-07-06 1991-05-28 Dana-Farber Cancer Institute Monoclonal antibody specific for the adhesion function domain of a phagocyte cell surface protein
DE68923107T2 (de) * 1988-02-26 1996-01-18 Biogen Inc DNA-Sequenzen, rekombinante DNA-Moleküle und Verfahren zur Herstellung von Lipocortin III, IV, V, und VI.
US5256642A (en) * 1988-04-01 1993-10-26 The Johns Hopkins University Compositions of soluble complement receptor 1 (CR1) and a thrombolytic agent, and the methods of use thereof
JPH05504470A (ja) * 1989-10-20 1993-07-15 ニューイングランド・メディカル・センター・ホスピタルズ・インコーポレーテッド Ｐａｄｇｅｍを介した細胞結合の阻害
US5314992A (en) * 1991-11-25 1994-05-24 Trustees Of Dartmouth College Lipocortin-1 receptor protein and its uses

Also Published As

Publication number Publication date
JPH07508177A (ja) 1995-09-14
NZ252591A (en) 1997-02-24
US6756211B1 (en) 2004-06-29
MX9302750A (es) 1994-02-28
ATE207498T1 (de) 2001-11-15
EP0731709B1 (en) 2001-10-24
NZ299623A (en) 2000-11-24
EP0731709A4 (en) 1997-06-11
JP3509860B2 (ja) 2004-03-22
EP0731709A1 (en) 1996-09-18
DE69331018T2 (de) 2002-06-13
DE69331018D1 (de) 2001-11-29
AU687737B2 (en) 1998-03-05
ES2168095T3 (es) 2002-06-01
NZ505450A (en) 2002-02-01
AU4246493A (en) 1993-12-13
CA2135390A1 (en) 1993-11-25
DK0731709T3 (da) 2002-02-11
WO1993023063A1 (en) 1993-11-25

Similar Documents

Publication Publication Date Title
CA2129339A1 (en) Inhibitors of thrombosis
CA2155931A1 (en) Inhibitors of thrombosis
GEP20012446B (en) Inhibitors of Interleukin- 1β Converting Enzyme
ATE249421T1 (de) Inhibitoren der alpha4-beta1 vermittelten zelladhäsion
TR199801168T2 (xx) �nterleukin-1 beta d�n��t�r�c� enzim inhibit�rleri.
DE69414115T2 (de) Vitamin d analoge
ATE199090T1 (de) Gegenüber eigenen inhibitoren resistente t-pa mutanten
FI951298A0 (fi) 2-amino-4-fenyyli-4-oksovoihappojohdannaiset, joilla on kynureninaasia ja/tai kynureniini-3-hydroksylaasia inhiboiva aktiivisuus
DE69915692D1 (de) Inhibitoren der alpha-4 beta-1 vermittelten zelladhäsion
PT731709E (pt) Inibidores de neutrofilos provenientes nematodos
ATE131071T1 (de) Leukozyten-adhäsions-inhibitor.
ES2186807T3 (es) Inhibidores de trombina.
NO951570D0 (no) Anti-inflammatorisk faktor, fremgangsmåte for isolering derav og anvendelse
DE69428041D1 (de) Inhibierung von Leukozytenadhäsion
DK0787007T3 (da) Antiinflammatorisk faktor, isoleringsfremgangsmåde og anvendelse
DE69307031D1 (de) Für Bearbeitung geeigneter Gussstahl
ES2087186T3 (es) Nuevas piperidinas sustituidas y su empleo como inhibidores de la sintesis de colesterol.
IT216252Z2 (it) Impianto aeroseparatore di corpi estranei provenienti dal terreno di raccolta per spinaci o altri vegetali
DE29517089U1 (de) Fachboden für Regale oder Schränke